drugset / Trial / NCT04762875
MGTA-145 + Plerixafor in the Mobilization of HSCs for Allogeneic Transplant in Hematologic Malignancies
NaSingle-groupOpen-labelTreatment
Summary
This research study tests a new medicine for mobilizing stem cells so they can be collected and used for allogeneic stem cell transplant for treatment of hematological malignancies. MGTA-145, the new medicine, will be given with plerixafor.
Timeline
- Start
- 2021-06-16
- Primary completion
- 2021-09-14
- Completion
- 2022-03-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MGTA-145 | Protein / enzyme biologic | — | Intravenous |
| Subject | Plerixafor | Small molecule | 240 ug/kg | Subcutaneous |